Clinical trial
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
NCT00967005 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
- Lead sponsor
- University of Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- August 31, 2014
- Enrollment
- 28 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.